Molecular biology in acute leukemia

被引：4

作者：

Camós M. ^{[1
]}

Colomer D. ^{[1
]}

机构：

[1] Unitat d'Hematopatologia, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer, 08036 Barcelona

来源：

Clinical and Translational Oncology | 2006年 / 8卷 / 8期

关键词：

Acute lymphoblastic leukemia; Acute myeloid leukemia; Molecular biology;

D O I：

10.1007/s12094-006-0060-6

中图分类号：

学科分类号：

摘要：

Acute leukemia is a clonal expansion of tumoral cells in bone marrow, blood or other tissues. The acute leukemias are classified as myeloid or lymphoid based on the lineage of the blast cells. Over the past three decades, remarkable advances have been made in the classification and treatment of acute leukemias. In the last years, the research into the molecular pathogenesis of acute leukemia has progressed. The knowledge of chromosomal translocations breakpoints and possible candidate oncogenes and tumor suppressor genes has allowed the integration of all these events into multistep cascades that impact specific signal transduction pathways and lead to leukemic transformation. © FESEO 2006.

引用

页码：550 / 559

页数：9

共 88 条

[61] Armstrong S.A., Look A.T., Molecular genetics of acute lymphoblastic leukemia, J Clin Oncol, 23, pp. 6306-6315, (2005)
[62] Pui C.H., Relling M.V., Downing J.R., Acute lymphoblastic leukemia, N Engl J Med, 350, pp. 1535-1548, (2004)
[63] Yeoh E.J., Ross M.E., Shurtleff S.A., Et al., Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling, Cancer Cell, 1, pp. 133-145, (2002)
[64] Armstrong S.A., Kung A.L., Mabon M.E., Et al., Inhibition of FLT3 in MLL Validation of a therapeutic target identified by gene expression based classification, Cancer Cell, 5, pp. 175-185, (2005)
[65] Taketani T., Taki T., Sugita K., Et al., FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy, Blood, 103, pp. 1085-1088, (2004)
[66] Sigvardsson M., Overlapping expression of early B-cell factor and basic helix-loop-helix proteins as a mechanisms to dictate B-lineage-specific activity of the lambda5 promoter, Mol Cell Biol, 20, pp. 5640-5654, (2000)
[67] Wong S., Witte O.N., The BCR-ABL story: Bench to bedside and back, Annu Rev Immunol, 22, pp. 247-306, (2004)
[68] Hubeek I., Stam R.W., Peters G.J., Et al., The human equilibrative nucleoside transporter 1 mediatesitro cytarabine sensitivity in childhood acute myeloid leukemia, Br J Cancer, 93, pp. 1588-1594, (2003)
[69] Grabher C., von Boehmer H., Look A.T., Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia, Nat Rev Cancer, 6, pp. 547-559, (2006)
[70] Baer R., TaL1, TAL2 and LYL1: A family of basic helix-loop-helix proteins implicated in T cell acute leukaemia, Semin Cancer Biol, 4, pp. 341-347, (1993)

← 1 2 3 4 5 6 7 8 9 →